Am I too late to act on the soaring BATS share price?

The BATS share price has surged more than 20% in under two months. Our writer considers whether he should add more of the stock to his portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Things have been looking up lately for shareholders in British American Tobacco (LSE: BATS). The BATS share price has jumped 21% since the start of last month, at the time of writing this article earlier today. Over the past year, though, the gain has been a more modest 13%.

After shares in the company moved up sharply in a matter of weeks, am I now too late to buy more for my portfolio?

Price increase drivers

A number of factors help explain the recent upward movement. In October, the US regulator the Food and Drug Administration (FDA) cleared BATS to market a line of e-cigarettes. That was the first time the FDA had given clearance to a vaping product. BATS has pinned a lot of hope on growing sales of non-cigarette products such as its vaping line. So the FDA approval was seen as positive for future revenues.

There has also recently been a move by many investors into more defensive stocks, such as tobacco. Indeed, the London company’s performance in the past year has been less impressive than that of US rival Philip Morris International. Its New York-listed shares have added 26% in the same period, twice the gain seen at BATS.

Is the BATS share price still cheap?

Even after the upward move, I still reckon BATS could climb higher. Compared to its historical price, it looks cheap to me. The shares are 34% below where they stood five years ago. The price-to-earnings ratio is around nine, which seems cheap. The dividend yield is 6.9%. Although that is lower than a few months ago due to the increased share price, it is still well above that of most FTSE 100 shares.

Last week, Barclays raised its target price on BATS. The bank said that the share looks cheap relative to its future earning potential. The bank also highlighted the fact that BATS reckons it can break even on its next generation products in 2025. If the company manages to hit that target, it would end the initial stage of developing a next gen portfolio. So far, the company has focused on growing revenues not aiming for profits. Moving into profit on sizeable, growing next gen revenues could help the company’s economics even in the face of declining cigarette demand in many markets. That could support a higher share price in future.

So far, though, it is not clear if next gen products will ever match the profit margins offered by cigarettes. So there is a risk that, even if the company can sustain its revenues over the long-term, profitability may fall. That could lead to a falling share price down the line as cigarette revenues and profits decline.

My next move

I already hold a sizeable BATS position. But despite that I would consider buying more of the company’s shares. Even though the share price increase means buying now offers me a lower yield than a few months ago, I still regard the company as attractive for its passive income potential.

On top of that, if the shares keep moving up, I may also be able to benefit from capital gains. I see that as plausible given the company’s relatively cheap valuation in recent years. Even after recent gains, I continue to see strong arguments to add more BATS shares to my portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Christopher Ruane owns shares in British American Tobacco. The Motley Fool UK has recommended Barclays and British American Tobacco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Here’s how someone could start investing in 2025 with just £1,000

Planning to start investing in 2025? This writer highlights two very different stocks that might be worth considering for a…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

I asked ChatGPT which UK stocks Warren Buffett might look to buy. It suggested these 5 names

ChatGPT has some ideas about FTSE 100 stocks Warren Buffett might have been buying. But Stephen Wright thinks a closer…

Read more »

Investing Articles

Up 14% today! Here’s one growth stock that Elon Musk likes

A UK growth stock has signed another contract with SpaceX. But does this mean it deserves a place in my…

Read more »

Investing Articles

I asked ChatGPT if the FTSE 100 would hit 10,000 this year. It’s feeling bullish!

The FTSE 100's flying and Harvey Jones is feeling bullish. His obvious next step was to ask a chatbot where…

Read more »

Investing Articles

Near 52-week lows, are these FTSE 100 stocks now unmissable bargains?

Two FTSE 100 titans just can't stop falling in value. Paul Summers looks at whether investors should see this as…

Read more »

Investing Articles

Bill Ackman just loaded up on this top stock for his FTSE 100-listed fund

The well-known hedge fund manager has announced a massive holding in this tech stock for his FTSE 100-listed investment trust.

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Billionaire Bill Ackman has just made a huge bet on this S&P 500 growth stock

Bill Ackman just bought 30m shares in this well-known S&P 500 company. He believes it’s currently trading well below its…

Read more »

Investing Articles

40 and no pension? Here’s what £400 a month in a Stocks and Shares ISA could become

It's never too late to start investing for retirement. Here's how regular contributions to a Stocks and Shares ISA could…

Read more »